Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

261 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Aniracetam reverses memory impairment in rats.
Martin JR, Moreau JL, Jenck F. Martin JR, et al. Among authors: moreau jl. Pharmacol Res. 1995 Feb;31(2):133-6. doi: 10.1016/1043-6618(95)80059-x. Pharmacol Res. 1995. PMID: 7596957
Deficits in reward sensitivity in a neurodevelopmental rat model of schizophrenia.
Le Pen G, Gaudet L, Mortas P, Mory R, Moreau JL. Le Pen G, et al. Among authors: moreau jl. Psychopharmacology (Berl). 2002 Jun;161(4):434-41. doi: 10.1007/s00213-002-1092-4. Epub 2002 Apr 20. Psychopharmacology (Berl). 2002. PMID: 12073172
The orphanin receptor agonist RO 64-6198 does not induce place conditioning in rats.
Le Pen G, Wichmann J, Moreau JL, Jenck F. Le Pen G, et al. Among authors: moreau jl. Neuroreport. 2002 Mar 25;13(4):451-4. doi: 10.1097/00001756-200203250-00018. Neuroreport. 2002. PMID: 11930159
Disruption of prepulse inhibition of startle reflex in a neurodevelopmental model of schizophrenia: reversal by clozapine, olanzapine and risperidone but not by haloperidol.
Le Pen G, Moreau JL. Le Pen G, et al. Among authors: moreau jl. Neuropsychopharmacology. 2002 Jul;27(1):1-11. doi: 10.1016/S0893-133X(01)00383-9. Neuropsychopharmacology. 2002. PMID: 12062902
Discovery of benzoylpiperazines as a novel class of potent and selective GlyT1 inhibitors.
Pinard E, Alberati D, Borroni E, Fischer H, Hainzl D, Jolidon S, Moreau JL, Narquizian R, Nettekoven M, Norcross RD, Stalder H, Thomas AW. Pinard E, et al. Among authors: moreau jl. Bioorg Med Chem Lett. 2008 Sep 15;18(18):5134-9. doi: 10.1016/j.bmcl.2008.07.086. Epub 2008 Jul 24. Bioorg Med Chem Lett. 2008. PMID: 18752953
RO4938581, a novel cognitive enhancer acting at GABAA alpha5 subunit-containing receptors.
Ballard TM, Knoflach F, Prinssen E, Borroni E, Vivian JA, Basile J, Gasser R, Moreau JL, Wettstein JG, Buettelmann B, Knust H, Thomas AW, Trube G, Hernandez MC. Ballard TM, et al. Among authors: moreau jl. Psychopharmacology (Berl). 2009 Jan;202(1-3):207-23. doi: 10.1007/s00213-008-1357-7. Epub 2008 Oct 21. Psychopharmacology (Berl). 2009. PMID: 18936916
Spatial and associative learning deficits induced by neonatal excitotoxic hippocampal damage in rats: further evaluation of an animal model of schizophrenia.
Le Pen G, Grottick AJ, Higgins GA, Martin JR, Jenck F, Moreau JL. Le Pen G, et al. Among authors: moreau jl. Behav Pharmacol. 2000 Jun;11(3-4):257-68. doi: 10.1097/00008877-200006000-00009. Behav Pharmacol. 2000. PMID: 11103880
Convulsions induced by centrally administered NMDA in mice: effects of NMDA antagonists, benzodiazepines, minor tranquilizers and anticonvulsants.
Moreau JL, Pieri L, Prud'hon B. Moreau JL, et al. Br J Pharmacol. 1989 Nov;98(3):1050-4. doi: 10.1111/j.1476-5381.1989.tb14637.x. Br J Pharmacol. 1989. PMID: 2574061 Free PMC article.
The 5-HT1A receptor agonist flesinoxan increases aversion in a model of panic-like anxiety in rats.
Jenck F, Martin JR, Moreau JL. Jenck F, et al. Among authors: moreau jl. J Psychopharmacol. 1999;13(2):166-70. doi: 10.1177/026988119901300209. J Psychopharmacol. 1999. PMID: 10475723
Urocortin, a novel neuropeptide with anxiogenic-like properties.
Moreau JL, Kilpatrick G, Jenck F. Moreau JL, et al. Neuroreport. 1997 May 6;8(7):1697-701. doi: 10.1097/00001756-199705060-00027. Neuroreport. 1997. PMID: 9189917
261 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback